Zenas Biopharma's Purchased 60,000: Insider Buy Deep Dive
A biotech CEO just bought a sizable chunk of his company’s stock. That move sparks questions about conviction, risk, ...
Uncover various ways to generate cash quickly and improve your financial health. Take action today to boost your income!
23,571 articlesA biotech CEO just bought a sizable chunk of his company’s stock. That move sparks questions about conviction, risk, ...
Analysts sometimes cut targets right before a big earnings release. This piece explains why that timing can mislead i...
Tariffs grabbed headlines, but markets can react to other forces just as sharply. This guide breaks down two addition...
Bank of America upgrades Oracle to Buy, signaling potential upside as AI-driven cloud demand and a massive backlog cr...
As Cognyte readies its Q1 2027 earnings report, investors want clarity on growth, margins, and cash flow. This guide ...
Amazon delivered strong AWS growth and solid Q1 results, but a large capex plan keeps investors wary. Still, a broad ...
Microsoft is riding a fast-growing AI wave, but its stock hasn’t followed the surge. Here’s how analysts and models v...
Investing in small biotech stocks offers the potential for outsized gains — but only with a clear process. This guide...
A biotech insider sale can spark questions about company momentum. This article digs into the Stoke Therapeutics CMO ...
Cathie Wood is known for bold bets, but recently her moves hint at bargain-hunting in big-name tech. This article bre...
Snap is playing a high-stakes game. This article breaks down snap’s specs gamble, what it would take for AR hardware ...
A hypothetical $10,000 Exxon investment at the outbreak of the Iran conflict has produced a mixed bag of results. Her...